Inter-ictal psychosis and its treatment in an adolescent with epilepsy and borderline intellectual functioning: A case report

Basit Öğe Kaydı
dc.authorscopusid14627787400
dc.authorscopusid34771809300
dc.authorscopusid55607933300
dc.authorscopusid36505125800
dc.authorscopusid16201704400
dc.authorscopusid6506391726
dc.contributor.authorTufan A.E.
dc.contributor.authorÖzel Ö.Ö.
dc.contributor.authorYilmaz S.
dc.contributor.authorU?urlu G.K.
dc.contributor.authorBilici R.
dc.contributor.authorNamli M.
dc.date.accessioned2024-08-04T20:01:10Z
dc.date.available2024-08-04T20:01:10Z
dc.date.issued2011
dc.departmentİnönü Üniversitesien_US
dc.description.abstractPsychosis seen in patients with epilepsy can be classified as "ictal", "post-ictal" or "inter-ictal" according to the time of onset of psychotic symptoms in relation with seizures. This case presentation was thought to be important because of problems in making the diagnosis of inter-ictal psychosis and that the literature in our country on the relationship of epilepsy and psychosis in childhood and adolescence is limited. Irritability, auditory and visual hallucinations and persecutory delusions that increase in between seizures and reduce with them were observed in a 14 years-old male patient. He has been receiving treatment for epilepsy since he was 7 years old. No other stressor or psychoactive substance use were defined. The patient was using carbamazepine 1200 mg/ day, levatiracetam 500 mg/ day and pyrimidone 500 mg/ day at the time of presentation. Epileptiform activity at the left fronto-temporo-central area was observed with electroencephalography while I.Q. was found to be 75 (Borderline IQ) with the Porteus Labyrinths test. The patient was thought to fulfill the diagnosis for Psychotic Disorder NOS (inter-ictal psychosis) developing on borderline intellectual functioning and quetiapine 25 mg/ day was started. The dose was titrated gradually to 200 mg/ day. Quetiapine can be a choice for the treatment of inter-ictal psychosis and that further studies are needed to better evaluate the prevalence and treatment response of psychotic symptoms in children and adolescents with epilepsy.en_US
dc.identifier.endpage53en_US
dc.identifier.issn1300-8773
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-79952000509en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage51en_US
dc.identifier.urihttps://hdl.handle.net/11616/91305
dc.identifier.volume49en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofYeni Symposiumen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEpilepsyen_US
dc.subjectInter ictal psychosisen_US
dc.subjectPsychosisen_US
dc.subjectQuetiapineen_US
dc.titleInter-ictal psychosis and its treatment in an adolescent with epilepsy and borderline intellectual functioning: A case reporten_US
dc.title.alternativeEpilepsi ve sinirda entelektüel i?şlevselli?i olan bir ergende i?nteriktal psikoz ve tedavisi: Vak'a takdimien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu